VASO-OCCLUSIVE PAIN EPISODE IN SICKLE CELL DISEASE
Clinical trials for VASO-OCCLUSIVE PAIN EPISODE IN SICKLE CELL DISEASE explained in plain language.
Never miss a new study
Get alerted when new VASO-OCCLUSIVE PAIN EPISODE IN SICKLE CELL DISEASE trials appear
Sign up with your email to follow new studies for VASO-OCCLUSIVE PAIN EPISODE IN SICKLE CELL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a contraceptive shot ease sickle cell pain?
Symptom relief Recruiting nowThis study looks at whether an injectable birth control called Depo-Provera can reduce painful episodes in women with sickle cell disease. About 65 adult women who regularly have sickle cell pain will take part. They will first go 3 months without hormonal birth control, then get…
Matched conditions: VASO-OCCLUSIVE PAIN EPISODE IN SICKLE CELL DISEASE
Phase: PHASE4 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated May 17, 2026 02:26 UTC
-
Could ketamine ease sickle cell pain and cut opioid use in kids?
Symptom relief Recruiting nowThis study is testing whether adding a low dose of ketamine to standard pain medicine (like morphine) can better relieve severe pain from sickle cell disease in children and young adults ages 5 to 20. Participants will be randomly assigned to receive either standard care plus ket…
Matched conditions: VASO-OCCLUSIVE PAIN EPISODE IN SICKLE CELL DISEASE
Phase: PHASE2 • Sponsor: Mohsen Saidinejad • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
Virtual reality offers new hope for sickle cell pain relief
Symptom relief Recruiting nowThis study tests whether using a virtual reality headset can help reduce pain for adults with sickle cell disease who are in the emergency room for a painful crisis. About 30 participants will receive either standard care alone or standard care plus a VR experience. The goal is t…
Matched conditions: VASO-OCCLUSIVE PAIN EPISODE IN SICKLE CELL DISEASE
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC